Metropolol has been approved by the U.S. Food and Drug Administration (FDA).

Mylan Laboratories, Inc., announced that the FDA has granted final approval for Mylan Pharmaceuticals' abbreviated new drug application, which provides for a new strength (25 mg) of metoprolol tartrate (a beta blocker).

President and COO Louis J. DeBone stated, "Mylan is the single largest generic supplier of metoprolol tartrate, in 50-mg and 100-mg strengths, in the United States. The addition of a new 25-mg strength further enhances our generic product portfolio and offers a convenient dosage alternative for patients and healthcare providers."

Please visit the official site of the FDA for further information.

 

FDA Information regarding Metoprolol

Why is this medication prescribed?

Other uses for this medicine

Dosage and using this medicine

What special precautions should I follow?

What should I do if I forget a dose?

What side effects can this medication cause?

What storage conditions are needed for this medicine?

In case of an emergency/overdose